tiprankstipranks
Travere Therapeutics (TVTX)
NASDAQ:TVTX
US Market

Travere Therapeutics (TVTX) Income Statement

Compare
446 Followers

Travere Therapeutics Income Statement

Last quarter (Q3 2024), Travere Therapeutics's total revenue was $62.90M, an increase of 69.56% from the same quarter last year. In Q3, Travere Therapeutics's net income was $-54.81M. See Travere Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 145.24M$ 212.02M$ 227.49M$ 198.32M$ 175.34M
Gross Profit
$ 133.79M$ 204.43M$ 220.71M$ 192.19M$ 170.10M
Operating Expenses
$ 521.93M$ 455.99M$ 360.21M$ 267.57M$ 269.91M
Depreciation and Amortization
$ 38.53M$ 20.72M$ 26.62M$ 25.79M$ 20.41M
EBITDA
$ -326.25M$ -299.42M$ -186.68M$ -143.95M$ -107.21M
Operating Income
$ -376.74M$ -251.56M$ -139.50M$ -75.38M$ -99.81M
Other Income/Expenses
$ 634.00K$ -11.34M$ 19.74M$ -113.41M$ -46.64M
Pretax Income
$ -376.11M$ -278.17M$ -179.68M$ -188.79M$ -146.45M
Net Income
$ -111.40M$ -278.48M$ -180.09M$ -169.43M$ -146.43M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.50$ -4.37$ -3.01$ -3.56$ -3.46
Diluted EPS
$ -1.50$ -4.37$ -3.01$ -3.56$ -3.46
Weighted Average Shares Outstanding
74.27M 63.76M 59.83M 47.54M 42.34M
Weighted Average Shares Outstanding (Diluted)
74.27M 63.76M 59.83M 47.54M 42.34M
Currency in USD

Travere Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis